KINGFA — Kingfa Science and Technology (India) Balance Sheet
0.000.00%
- IN₹64.10bn
- IN₹64.21bn
- IN₹17.45bn
- 64
- 11
- 96
- 62
Annual balance sheet for Kingfa Science and Technology (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 240 | 294 | 242 | 51.1 | 237 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,238 | 3,124 | 4,101 | 4,648 | 5,120 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,122 | 6,123 | 7,380 | 7,254 | 8,541 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,517 | 2,528 | 2,544 | 2,541 | 2,849 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,710 | 8,800 | 10,103 | 9,944 | 11,556 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,845 | 4,709 | 5,394 | 4,021 | 4,222 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,171 | 4,954 | 5,443 | 4,059 | 4,270 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 3,540 | 3,846 | 4,660 | 5,886 | 7,286 |
| Total Liabilities & Shareholders' Equity | 6,710 | 8,800 | 10,103 | 9,944 | 11,556 |
| Total Common Shares Outstanding |